These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 7910987

  • 1. The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation.
    Sugita K, Soiffer RJ, Murray C, Schlossman SF, Ritz J, Morimoto C.
    Transplantation; 1994 May 27; 57(10):1465-73. PubMed ID: 7910987
    [Abstract] [Full Text] [Related]

  • 2. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D, García-López J, Sureda A, Canals C, Ferra C, Cancelas JA, Berlanga JJ, Brunet S, Boqué C, Picón M, Torrico C, Amill B, Martino R, Martínez C, Martín-Henao G, Domingo-Albós A, Grañena A.
    Bone Marrow Transplant; 1997 Dec 27; 20(11):945-52. PubMed ID: 9422473
    [Abstract] [Full Text] [Related]

  • 3. Generation of CD8 cytolytic T cells early after autologous or allogeneic bone marrow transplantation.
    Charmot D, Ragueneau M, Olive D, Maraninchi D, Mawas C.
    Bone Marrow Transplant; 1987 Aug 27; 2(2):183-94. PubMed ID: 2901879
    [Abstract] [Full Text] [Related]

  • 4. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M, Yabe H, Hattori K, Hinohara T, Morimoto T, Kato S, Kusunoki A.
    Bone Marrow Transplant; 1994 Nov 27; 14(5):741-6. PubMed ID: 7889006
    [Abstract] [Full Text] [Related]

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 27; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 6. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD, Becker EE, LaBelle JL, Truitt RL.
    J Immunol; 1999 Dec 15; 163(12):6479-87. PubMed ID: 10586039
    [Abstract] [Full Text] [Related]

  • 7. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP, Gratama JW, Lamers C, van Esser JW, Bolhuis RL, Cornelissen JJ.
    Bone Marrow Transplant; 1999 May 15; 23(10):1013-7. PubMed ID: 10373067
    [Abstract] [Full Text] [Related]

  • 8. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H, Nakamura H, Tominaga N, Teshima H, Hiraoka A, Shibata H, Masaoka T.
    Bone Marrow Transplant; 1994 Feb 15; 13(2):181-5. PubMed ID: 7515741
    [Abstract] [Full Text] [Related]

  • 9. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C, Roldán E, Rodríguez C, Pérez de Oteyza J, Oteho E, López J, Maldonado MS, García Laraña J, Muñoz A, Odriozola J, Brieva JA.
    Med Clin (Barc); 1999 Jun 12; 113(1):1-5. PubMed ID: 10422068
    [Abstract] [Full Text] [Related]

  • 10. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ, Abe F, Buyukberber S, Ino K, Talmadge JE.
    In Vivo; 2000 Jun 12; 14(1):221-36. PubMed ID: 10757081
    [Abstract] [Full Text] [Related]

  • 11. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation.
    Koehne G, Zeller W, Stockschlaeder M, Zander AR.
    Bone Marrow Transplant; 1997 Jan 12; 19(2):149-56. PubMed ID: 9116612
    [Abstract] [Full Text] [Related]

  • 12. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation.
    de Vries E, van Tol MJ, van den Bergh RL, Waaijer JL, ten Dam MM, Hermans J, Vossen JM.
    Bone Marrow Transplant; 2000 Feb 12; 25(3):267-75. PubMed ID: 10673698
    [Abstract] [Full Text] [Related]

  • 13. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation.
    Rojas B, Cuhna R, Zafirakis P, Ramirez JM, Lizan-garciía M, Zhao T, Foster CS.
    Exp Eye Res; 2005 Sep 12; 81(3):313-25. PubMed ID: 16129099
    [Abstract] [Full Text] [Related]

  • 14. T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow.
    Janossy G, Prentice HG, Grob JP, Ivory K, Tidman N, Grundy J, Favrot M, Brenner MK, Campana D, Blacklock HA.
    Clin Exp Immunol; 1986 Mar 12; 63(3):577-86. PubMed ID: 3011326
    [Abstract] [Full Text] [Related]

  • 15. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM, Waller EK.
    Biol Blood Marrow Transplant; 2004 Aug 12; 10(8):540-51. PubMed ID: 15282532
    [Abstract] [Full Text] [Related]

  • 16. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
    Ewing P, Miklos S, Olkiewicz KM, Müller G, Andreesen R, Holler E, Cooke KR, Hildebrandt GC.
    Exp Hematol; 2007 Jan 12; 35(1):155-63. PubMed ID: 17198884
    [Abstract] [Full Text] [Related]

  • 17. Immunomagnetic CD4+ and CD8+ cell depletion for patients at high risk for severe acute GVHD.
    Jansen J, Hanks S, Akard LP, Thompson JM, Burns S, Chang Q, English D, Garrett P.
    Bone Marrow Transplant; 1996 Mar 12; 17(3):377-82. PubMed ID: 8704690
    [Abstract] [Full Text] [Related]

  • 18. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F, Carotenuto M.
    Haematologica; 1998 Mar 12; 83(3):197-203. PubMed ID: 9573672
    [Abstract] [Full Text] [Related]

  • 19. CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
    Soiffer RJ, Freedman AS, Neuberg D, Fisher DC, Alyea EP, Gribben J, Schlossman RL, Bartlett-Pandite L, Kuhlman C, Murray C, Freeman A, Mauch P, Anderson KC, Nadler LM, Ritz J.
    Bone Marrow Transplant; 1998 Jun 12; 21(12):1177-81. PubMed ID: 9674848
    [Abstract] [Full Text] [Related]

  • 20. Marked increase of CD57+CD16- cells in long-term survivors of graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H, Nakamura H, Tominaga N, Teshima H, Hiraoka A, Shibata H, Masaoka T.
    Jpn J Clin Oncol; 1992 Aug 12; 22(4):238-43. PubMed ID: 1359173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.